Skip to main content
. Author manuscript; available in PMC: 2020 Sep 4.
Published in final edited form as: Circ Heart Fail. 2019 Sep 4;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075

Table 1.

Diagnostic Clues to ATTR-CM

History/examination clues
 • Evidence of right-sided heart failure (eg, hepatomegaly, ascites, and lower extremity edema)
 • HFpEF, particularly in men
 • Intolerance to ACE inhibitors or beta blockers
 • Bilateral carpal tunnel syndrome
 • Lumbar spinal stenosis
 • Biceps tendon rupture
 • Unexplained peripheral neuropathy (eg, loss of warm/cold discrimination), particularly if associated with autonomic dysfunction (eg, postural hypotension, alternating bowel pattern)
 • Unexplained atrial arrhythmias or conduction system disease/need for a pacemaker
Imaging clues
 • Myocardial uptake on PYP/DPD or HMDP imaging
 • “Infiltrative phenotype” (eg, biventricular hypertrophy pericardial effusion, valve thickening, interatrial septal thickening)
 • Diffuse subendocardial or transmural LGE or increased ECV fraction on cardiac MRI
 • Apical sparing on longitudinal strain imaging
 • Low myocardial contraction fraction
 • Restrictive LV filling with RV wall thickening
Combined clues
 • HF with unexplained increased LV wall thickening and nondilated LV
 • Concentric LV wall thickening, possibly with an abnormal QRS voltage-to-LV thickness ratio
 • Depressed longitudinal LV function despite normal EF
 • Aortic stenosis with RV thickening, particularly if paradoxical low flow/low gradient

ACE, angiotensin-converting enzyme; ATTR-CM, transthyretin amyloidosis with predominant cardiomyopathy; DPD, diphosphono-1,2-propanodicarboxylic acid; ECV, extracellular volume; EF, ejection fraction; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HMDP, hydroxymethylene diphosphonate; LGE, late gadolinium enhancement; LV, left ventricular; MRI, magnetic resonance imaging; PYP, pyrophosphate; RV, right ventricular.

The sensitivity and specificity of these “clues” has not been delineated in population-based samples with heart failure.